Shanghai RAAS Blood Products Co., Ltd.
002252
Rank in Stocks
#3556
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Share Price
$0.7157778
Market Cap
$4.72B
Change (1 day)
-1.44%
Change (1 year)
-23.98%
Country
CN
Trade Shanghai RAAS Blood Products Co., Ltd. (002252)
Category
Healthcare
Stock price history for Shanghai RAAS Blood Products Co., Ltd. (002252)
Highest end of day price: $0.72 on 2026-10-01
Lowest end of day price: $0.31 on 2008-06-01
Lowest end of day price: $0.31 on 2008-06-01
Stock price history of Shanghai RAAS Blood Products Co., Ltd. from 2008 to 2026
Annual Stock Price Performance
| Year | Performance |
|---|---|
| 2026 (TTM) | -10.94% |
| 2025 | -9.89% |
| 2024 | -10.82% |
| 2023 | 37.89% |
| 2022 | -19.09% |
| 2021 | -14.15% |
| 2020 | 14.88% |
| 2019 | -39.74% |
| 2018 | -42.57% |
| 2017 | -5.12% |
| 2016 | -8.73% |
| 2015 | 68.38% |
| 2014 | 1.42% |
| 2013 | 244.29% |
| 2012 | 1.81% |
| 2011 | -31.43% |
| 2010 | 83.78% |
| 2009 | 43.19% |
| 2008 | 0.00% |
Stock price for similar companies or competitors
| Company | Stock price | Change 1y% | Country |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $763.55 | 8.53% |
CH
|
